Evolution-Driven Attenuation of Alphaviruses Highlights Key Glycoprotein Determinants Regulating Viral Infectivity and Dissemination.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
09 07 2019
Historique:
received: 17 12 2018
revised: 08 05 2019
accepted: 05 06 2019
entrez: 11 7 2019
pubmed: 11 7 2019
medline: 29 9 2020
Statut: ppublish

Résumé

Understanding the fundamental mechanisms of arbovirus transmission and pathogenesis is essential to develop strategies for treatment and prevention. We previously took an in vivo evolution-based approach and identified the chikungunya virus E1 glycoprotein residue 80 to play a critical role in viral transmission and pathogenesis. In this study, we address the genetic conservation and function of position 80 and demonstrate that this residue is a key determinant in alphavirus infectivity and dissemination through modulation of viral fusion and cholesterol dependence. In addition, in studying the evolution of position 80, we identified a network of glycoprotein residues, including epidemic determinants, that regulate virus dissemination and infectivity. These studies underscore the importance of taking evolution-based approaches to not only identify key viral determinants driving arbovirus transmission and pathogenesis but also to uncover fundamental aspects of arbovirus biology.

Identifiants

pubmed: 31291581
pii: S2211-1247(19)30788-0
doi: 10.1016/j.celrep.2019.06.022
pmc: PMC7141928
mid: NIHMS1575554
pii:
doi:

Substances chimiques

Glycoproteins 0
Viral Envelope Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

460-471.e5

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI007180
Pays : United States

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Virology. 2018 Feb;515:223-234
pubmed: 29306785
Nature. 2018 May;557(7706):570-574
pubmed: 29769725
PLoS Med. 2006 Jul;3(7):e263
pubmed: 16700631
PLoS Pathog. 2007 Dec;3(12):e201
pubmed: 18069894
Nature. 2010 Dec 2;468(7324):709-12
pubmed: 21124458
J Cell Biol. 1984 Jan;98(1):139-45
pubmed: 6707081
J Cell Biol. 1998 Jan 12;140(1):91-9
pubmed: 9425157
Subcell Biochem. 2000;34:409-55
pubmed: 10808340
Front Immunol. 2018 Jan 16;8:1993
pubmed: 29387061
Am J Trop Med Hyg. 2007 Aug;77(2):365-70
pubmed: 17690414
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Vector Borne Zoonotic Dis. 2015 Apr;15(4):231-40
pubmed: 25674945
PLoS Pathog. 2011 Dec;7(12):e1002412
pubmed: 22174678
Nat Rev Microbiol. 2006 Jan;4(1):67-76
pubmed: 16357862
PLoS One. 2007 Nov 14;2(11):e1168
pubmed: 18000540
J Virol. 2009 Sep;83(18):9113-21
pubmed: 19587056
J Virol. 2010 Aug;84(16):8021-32
pubmed: 20519386
J Virol. 2002 Feb;76(3):1194-205
pubmed: 11773395
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11344-9
pubmed: 15277679
mBio. 2017 Feb 14;8(1):
pubmed: 28196962
J Virol. 2017 Oct 27;91(22):
pubmed: 28835505
Nat Commun. 2017 May 19;8:15412
pubmed: 28524874
Virus Evol. 2018 Jun 04;4(1):vey012
pubmed: 29942653
Virology. 2012 Apr 10;425(2):103-12
pubmed: 22305131
Methods Mol Biol. 2015;1232:91-102
pubmed: 25331130
Am J Trop Med Hyg. 2004 Oct;71(4):493-500
pubmed: 15516648
J Virol. 2016 Apr 14;90(9):4745-4756
pubmed: 26912616
J Virol. 1999 May;73(5):4272-8
pubmed: 10196324
Oncotarget. 2017 Apr 25;8(35):58668-58685
pubmed: 28938587
Lancet Infect Dis. 2017 Mar;17(3):e101-e106
pubmed: 28011234
J Virol. 2011 Jul;85(13):6334-42
pubmed: 21543498
Science. 2017 Nov 3;358(6363):663-667
pubmed: 29097548
Nat Commun. 2014 Jun 16;5:4084
pubmed: 24933611
Infect Genet Evol. 2012 Mar;12(2):181-90
pubmed: 22226703
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Cell. 2003 Sep 5;114(5):573-83
pubmed: 13678581
Cell. 2018 Mar 8;172(6):1319-1334
pubmed: 29522750
J Virol. 2005 Jul;79(14):9128-33
pubmed: 15994807
Sci Rep. 2017 Nov 7;7(1):14641
pubmed: 29116243
PLoS Pathog. 2007 Jun;3(6):e89
pubmed: 17604450
Cell. 2015 Dec 17;163(7):1716-29
pubmed: 26686653
Annu Rev Virol. 2017 Sep 29;4(1):181-200
pubmed: 28961411
Biochim Biophys Acta. 2007 Jun;1768(6):1311-24
pubmed: 17493580
Virol J. 2011 Jul 29;8:376
pubmed: 21801412
Nat Microbiol. 2018 Oct;3(10):1131-1141
pubmed: 30202015
J Virol. 2013 Jul;87(13):7680-7
pubmed: 23637415
J Virol. 2011 Jan;85(2):1025-35
pubmed: 21047966
Cell Host Microbe. 2014 Jun 11;15(6):706-16
pubmed: 24922573

Auteurs

Maria G Noval (MG)

Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA.

Bruno A Rodriguez-Rodriguez (BA)

Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA.

Margarita V Rangel (MV)

Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA.

Kenneth A Stapleford (KA)

Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA. Electronic address: kenneth.stapleford@nyumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH